Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$4.43
-4.1%
$4.85
$3.42
$9.35
$248.29M1.713.04 million shs1.01 million shs
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
$22.39
+3.8%
$21.89
$10.00
$28.42
$245.24M0.8867,606 shs77,383 shs
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
$0.92
-7.5%
$1.22
$0.91
$7.80
$59.10M1.32495,155 shs562,870 shs
2seventy bio, Inc. stock logo
TSVT
2seventy bio
$4.95
$3.24
$2.29
$5.99
$255.36M1.73605,922 shs445,240 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.00%-0.67%-13.14%+5.48%+0.91%
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
0.00%-0.36%-10.08%-11.33%+21.68%
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
0.00%-5.55%-23.33%-67.38%-87.99%
2seventy bio, Inc. stock logo
TSVT
2seventy bio
0.00%0.00%+87.50%+71.28%-7.48%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.3023 of 5 stars
0.02.00.00.01.50.80.6
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
4.3541 of 5 stars
4.63.00.04.62.40.80.0
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
3.7081 of 5 stars
4.53.00.00.03.12.50.6
2seventy bio, Inc. stock logo
TSVT
2seventy bio
3.1055 of 5 stars
3.24.00.00.02.32.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
3.67
Strong BuyN/AN/A
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
3.25
Buy$39.1474.82% Upside
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
3.00
Buy$14.561,482.13% Upside
2seventy bio, Inc. stock logo
TSVT
2seventy bio
2.38
Hold$6.6734.68% Upside

Current Analyst Ratings Breakdown

Latest INZY, CDTX, ACB, and TSVT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2025
2seventy bio, Inc. stock logo
TSVT
2seventy bio
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (D-) ➝ Sell (E+)
3/14/2025
2seventy bio, Inc. stock logo
TSVT
2seventy bio
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$6.00 ➝ $5.00
3/12/2025
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
3/12/2025
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$46.00
3/12/2025
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
Citizens Jmp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$46.00
3/12/2025
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$24.00 ➝ $12.00
3/11/2025
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$30.00 ➝ $23.00
3/11/2025
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00 ➝ $16.00
3/11/2025
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$23.00 ➝ $15.00
3/11/2025
2seventy bio, Inc. stock logo
TSVT
2seventy bio
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
3/11/2025
2seventy bio, Inc. stock logo
TSVT
2seventy bio
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform$9.00 ➝ $5.00
(Data available from 3/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$320.81M0.77$0.17 per share26.35$8.18 per share0.54
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
$1.28M192.34N/AN/A($1.82) per share-12.30
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
N/AN/AN/AN/A$2.27 per shareN/A
2seventy bio, Inc. stock logo
TSVT
2seventy bio
$45.62M5.60N/AN/A$5.04 per share0.98
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$48.62M$0.0588.6210.07N/A0.42%0.59%0.42%6/19/2025 (Estimated)
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
-$22.93M-$30.09N/AN/AN/A-289.05%-69.64%-33.73%4/28/2025 (Estimated)
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
-$71.17M-$1.63N/AN/AN/AN/A-88.42%-57.02%5/6/2025 (Estimated)
2seventy bio, Inc. stock logo
TSVT
2seventy bio
-$217.57M-$1.12N/AN/AN/A-207.25%-53.65%-23.67%5/1/2025 (Estimated)

Latest INZY, CDTX, ACB, and TSVT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/25/2025Q4 2024
2seventy bio, Inc. stock logo
TSVT
2seventy bio
-$0.23-$0.31-$0.08-$0.37$12.84 million$2.93 million
3/6/2025Q4 2024
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
-$5.28-$5.38-$0.10-$5.37N/AN/A
2/5/2025Q3 2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$0.09$0.06+$0.15$0.41$80.01 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
N/AN/AN/AN/AN/A
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
N/AN/AN/AN/AN/A
2seventy bio, Inc. stock logo
TSVT
2seventy bio
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.07
3.30
1.60
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
N/A
3.54
3.54
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
0.51
7.68
7.68
2seventy bio, Inc. stock logo
TSVT
2seventy bio
N/A
4.95
4.95

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
35.82%
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
88.30%
2seventy bio, Inc. stock logo
TSVT
2seventy bio
93.90%

Insider Ownership

CompanyInsider Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
7.64%
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
11.19%
2seventy bio, Inc. stock logo
TSVT
2seventy bio
7.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,34056.05 million54.85 millionOptionable
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
9010.95 million6.51 millionNo Data
Inozyme Pharma, Inc. stock logo
INZY
Inozyme Pharma
5064.24 million57.05 millionOptionable
2seventy bio, Inc. stock logo
TSVT
2seventy bio
44051.59 million47.87 millionOptionable

Recent News About These Companies

2seventy Bio reports Q4 EPS (37c) vs ($1.11) last year
2seventy Bio price target lowered to $5 from $6 at Morgan Stanley

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$4.43 -0.19 (-4.11%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$4.47 +0.04 (+1.02%)
As of 03/28/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Cidara Therapeutics stock logo

Cidara Therapeutics NASDAQ:CDTX

$22.39 +0.81 (+3.75%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$21.97 -0.42 (-1.88%)
As of 03/28/2025 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. The company was incorporated in 2012 and is based in San Diego, California.

Inozyme Pharma stock logo

Inozyme Pharma NASDAQ:INZY

$0.92 -0.07 (-7.51%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$0.96 +0.04 (+4.89%)
As of 03/28/2025 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, as well as patients with end-stage kidney disease receiving hemodialysis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

2seventy bio stock logo

2seventy bio NASDAQ:TSVT

$4.95 0.00 (0.00%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$4.93 -0.02 (-0.30%)
As of 03/28/2025 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.